Reduce Your Levothyroxine Dose
You should decrease your levothyroxine dose by 12.5 to 25 mcg to bring your TSH back into the normal reference range. With a TSH of 0.11 mIU/L (below 0.1 mIU/L) and normal free T4, you have exogenous subclinical hyperthyroidism from overreplacement, which carries risks of atrial fibrillation, bone loss, and cardiovascular complications—particularly if you are over 60 years old 1.
Why This Matters for Your Health
Your suppressed TSH indicates you're receiving more levothyroxine than needed for simple hypothyroidism replacement. The 2004 JAMA guidelines explicitly state that when TSH is below 0.1 mIU/L in levothyroxine-treated individuals without thyroid cancer or nodules, the dose should be decreased to allow TSH to increase toward the reference range 1. This is critical because:
- Cardiovascular risk: Subclinical hyperthyroidism with TSH <0.1 mIU/L increases risk of atrial fibrillation and cardiovascular mortality, especially in elderly patients 1
- Bone health: Overtreatment accelerates bone loss, particularly concerning for postmenopausal women 2
- No benefit: There's no therapeutic advantage to TSH suppression when treating simple hypothyroidism 2
How to Adjust Your Dose
Reduce from 125 mcg to either 112.5 mcg or 100 mcg daily 2. The FDA label and clinical guidelines recommend dose adjustments of 12.5-25 mcg increments 3. Based on a practical study of 601 patients with suppressed TSH:
- If reducing by 25 mcg (to 100 mcg): 42.8% achieved normal TSH, only 3.8% became hypothyroid 4
- If reducing by 12.5 mcg (to 112.5 mcg): More conservative approach with lower risk of overcorrection
Recheck TSH and free T4 in 6-8 weeks after the dose change 3. The guidelines are clear that TSH assessment should occur 6-8 weeks after any dosage adjustment to allow levels to stabilize 2.
Critical Context: Rule Out Special Circumstances
Before reducing, confirm you don't have:
- Thyroid cancer history: If you've had thyroid cancer, TSH suppression may be intentional and therapeutic—do not adjust without consulting your endocrinologist 1
- Thyroid nodules requiring suppression: Some nodular disease requires lower TSH targets 1
- Recent medication changes: Drugs affecting levothyroxine absorption (iron, calcium, proton pump inhibitors) or metabolism can alter requirements 2
If you have none of these conditions, dose reduction is appropriate and recommended to prevent the adverse cardiovascular and skeletal consequences of chronic overtreatment 2.
Common Pitfalls to Avoid
- Don't wait to adjust: Prolonged TSH suppression increases cumulative risk of complications 1
- Don't reduce too aggressively: A 50 mcg reduction from 125 mcg would likely overcorrect and cause hypothyroidism 4
- Don't skip follow-up testing: You must verify the new dose achieves euthyroidism; 54.4% of patients remain suppressed even after dose reduction 4
- Consider your age: If you're over 60, dose reduction is particularly important given higher cardiovascular risk 1, 2
The 2012 AACE/ATA guidelines emphasize that apart from pregnancy and thyroid cancer, there's no evidence supporting targeting specific TSH values within the normal range—but staying within the normal range itself is essential 2.